Notice of extraordinary general meeting
Filed with HKEX · Stock code 1952 · · 3 pages · English
Summary by 6ix AI
Everest Medicines Ltd. has issued a notice for an extraordinary general meeting to be held virtually. The meeting will discuss the approval of a strategic cooperation framework agreement with Hasten Biopharmaceutical Co., Ltd. Shareholders can participate and vote online without needing to attend in person. The notice includes details on proxy voting and the process for submitting questions during the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Everest Medicines
- (1) Continuing connected transactions in relation to the strategic cooperation framework agreement; and (2) notice of extraordinary general meeting
- Book closure period for extraordinary general meeting
- Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Terms of reference of the environmental, social and governance committee
Later from Everest Medicines
- Form of proxy for the extraordinary general meeting to be held on Monday, 16 November 2026
- The Strategic Cooperation Framework Agreement
- Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Extraordinary General Meeting
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Everest Medicines into a list and get an email when it puts out news.
Follow Everest Medicines